THE RESPONSE OF PERIPHERAL-BLOOD STEM-CELLS TO STANDARD CHEMOTHERAPY FOR LYMPHOMA

被引:12
作者
CRAIG, JIO
SMITH, SM
PARKER, AC
ANTHONY, RS
机构
[1] Department of Haematology, The Royal Infirmary of Edinburgh, Scotland
关键词
PERIPHERAL BLOOD STEM CELLS; CFU-GM; CFU-GEMM; LYMPHOMA CHEMOTHERAPY;
D O I
10.3109/10428199209053568
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peripheral blood stem cells (PBSC) represent an alternative to bone marrow for autologous transplantation. These progenitors are found in the blood in greatly increased numbers after chemotherapy for acute leukaemia and after high dose cyclophosphamide when they can be harvested. We have assessed the response of colony forming units-granulocyte monocyte (CFU-GM) and colony forming units-granulocyte, erythroid, monocyte, megakaryocyte (CFU-GEMM) in 46 patients with lymphoma undergoing standard chemotherapy. Seventeen out of 18 patients with non Hodgkin's lymphoma (NHL) receiving CHOP had a 6.9 fold increase over baseline in CFU-GM and a 5 fold increase in CFU-GEMM occurring on day 19. In 3 patients with NHL, ALL type therapy induced a 17.5 and 16 fold increase in these progenitors occurring on day 21. Only 4 of the 10 patients with Hodgkin's disease (HD) treated with ChIVPP demonstrated a rise in progenitors and only to 3.3 and 2.7 fold in CFU-GM and CFU-GEMM respectively. ABVD similarly produced increases in only 5/9 patients and MOPP in 3/5. HOPE-bleo increased circulating CFU-GM 16.3 fold and CFU-GEMM 12.4 fold. Bone marrow involvement significantly reduced the peak levels of CFU-GM (p = 0.0017) as did second or subsequent line chemotherapy (p = 0.0001). Thus standard chemotherapy regimes for lymphoma can induce a rise in circulating progenitors in the majority of patients. Peripheral blood stem cell harvesting should be performed during first line chemotherapy as blood counts are recovering and should be repeated after each cycle. © 1992 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 25 条
[1]  
Goodman J.W., Hodgson G.S., Evidence for stem cells in the peripheral blood of mice, Blood, 19, pp. 702-714, (1962)
[2]  
Cavins J.A., Scheer S.C., Thomas E.D., Ferrebee J.W., The recovery of lethally irradiated dogs given infusion of autologous leukocytes preserved at - 80°C, Blood, 23, pp. 38-43, (1964)
[3]  
Kurnick J.E., Robinson W.A., Colony growth of human peripheral white blood cells in vitro, Blood, 37, pp. 136-141, (1971)
[4]  
Chervenick P.A., Boggs D.R., vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals, Blood, 37, pp. 131-135, (1971)
[5]  
Kessinger A., Armitage J.O., Smith D.M., Landmark J.D., Bierman P.J., Weisenburger D.D., High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma, Blood, 74, pp. 1260-1265, (1989)
[6]  
Zander A.R., Cockerill K.J., Autologous transplantation with circulating hemopoietic stem cells, Journal of Clinical Apheresis, 3, pp. 191-201, (1987)
[7]  
Barrett A.J., Longhurst P., Sneath P., Watson J.G., Mobilisation of CFU-C by exercise and ACTH induced stress in man, Experimental Hematology, 6, pp. 590-594, (1978)
[8]  
Morra L., Ponassi A., Parodi G.B., Caristo G., Bruzzi P., Sacchetti C., Mobilization of colony-forming cells (CFU-C) into the peripheral blood of man by hydrocortisone, Biomedicine, 35, pp. 87-90, (1981)
[9]  
Richman C.M., Weiner R.S., Yankee R.A., Increase in circulating stem cells following chemotherapy in man, Blood, 47, pp. 1031-1039, (1976)
[10]  
To L.B., Haylock D.N., Kimber R.J., Juttner C.A., High levels of circulating haemopoietic stem cells in very early remission from acute nonlymphoblastic leukaemia and their collection and cryopreservation, British Journal of Haematology, 58, pp. 399-410, (1984)